Attenuated antigen-specific T cell responses in cirrhosis are accompanied by elevated serum interleukin-10 levels and down-regulation of HLA-DR on monocytes

BMC Gastroenterology

Volumn 13, Issue 1, 2013, Pages

  Peter, Jack ^a   Frey, Oliver ^a   Stallmach, Andreas ^a   Bruns, Tony ^a,b  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Adaptive immunity; Bacterial translocation; Cellular immunity; Cirrhosis; Interleukin 10; Virus specific T cell responses

Indexed keywords

C REACTIVE PROTEIN; CD14 ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN 1; GAMMA INTERFERON; HLA DR ANTIGEN; IMMEDIATE EARLY PROTEIN BZLF1; INTERLEUKIN 10; LIPOPOLYSACCHARIDE BINDING PROTEIN; STAPHYLOCOCCUS ENTEROTOXIN B; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL TRANSLOCATION; CD4 LYMPHOCYTE COUNT; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL STIMULATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DOWN REGULATION; ENDOTOXEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; LIVER CIRRHOSIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MONOCYTE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL;

ACUTE-PHASE PROTEINS; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD14; C-REACTIVE PROTEIN; CARRIER PROTEINS; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; FEMALE; HLA-DR ANTIGENS; HUMANS; INFLAMMATION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKINS; LIVER CIRRHOSIS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MONOCYTES;

EID: 84874224088     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-13-37     Document Type: Article

References (43)

1. Borzio M, Salerno F, Piantoni L, Cazzaniga M, Angeli P, Bissoli F, Boccia S, Colloredo-Mels G, Corigliano P, Fornaciari G, Marenco G, Pistarà R, Salvagnini M, Sangiovanni A. Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis 2001, 33:41-48. 10.1016/S1590-8658(01)80134-1, 11303974.
2. Arvaniti V, D'Amico G, Fede G, Manousou P, Tsochatzis E, Pleguezuelo M, Burroughs AK. Infections in Patients With Cirrhosis Increase Mortality Four-Fold and Should Be Used in Determining Prognosis. Gastroenterology 2010, 139:1246-1256. e5, 10.1053/j.gastro.2010.06.019, 20558165.
3. Gustot T, Durand F, Lebrec D, Vincent J-L, Moreau R. Severe sepsis in cirrhosis. Hepatology 2009, 50:2022-2033. 10.1002/hep.23264, 19885876.
4. Gomez F, Ruiz P, Schreiber AD. Impaired function of macrophage Fc gamma receptors and bacterial infection in alcoholic cirrhosis. N Engl J Med 1994, 331:1122-1128. 10.1056/NEJM199410273311704, 7935636.
5. Bruns T, Peter J, Hagel S, Herrmann A, Stallmach A. The augmented neutrophil respiratory burst in response to Escherichia coli is reduced in liver cirrhosis during infection. Clin Exp Immunol 2011, 164:346-356. 10.1111/j.1365-2249.2011.04373.x, 3087930, 21413941.
6. Fiuza C, Salcedo M, Clemente G, Tellado JM. In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease. J Infect Dis 2000, 182:526-533. 10.1086/315742, 10915084.
7. Masini E, Mugnai L, Foschi M, Laffi G, Gentilini P, Mannaioni PF. Changes in the production of nitric oxide and superoxide by inflammatory cells in liver cirrhosis. Int Arch Allergy Immunol 1995, 107:197-198. 10.1159/000236975, 7613130.
8. Tritto G, Bechlis Z, Stadlbauer V, Davies N, Francés R, Shah N, Mookerjee RP, Such J, Jalan R. Evidence of neutrophil functional defect despite inflammation in stable cirrhosis. J Hepatol 2011, 55:574-581. 10.1016/j.jhep.2010.11.034, 21236309.
9. Laso FJ, Madruga JI, Girón JA, López A, Ciudad J, San Miguel JF, Alvarez-Mon M, Orfao A. Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption. Hepatology 1997, 25:1096-1100. 10.1002/hep.510250508, 9141423.
10. Homann C, Varming K, Høgåsen K, Mollnes TE, Graudal N, Thomsen AC, Garred P. Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality. Gut 1997, 40:544-549. 1027133, 9176087.
11. Rožnovský L, Orságová I, Petroušová L, Tvrdík J, Kabieszová L, Rydlo M, Lochman I, Kloudová A. [Low response rate to a vaccination against hepatitis B in patients with end-stage liver disease]. Klin Mikrobiol Infekc Lek 2010, 16:179-181.
12. Cheong H-J, Song J-Y, Park J-W, Yeon J-E, Byun K-S, Lee C-H, Cho H-I, Kim T-G, Kim W-J. Humoral and cellular immune responses to influenza vaccine in patients with advanced cirrhosis. Vaccine 2006, 24:2417-2422. 10.1016/j.vaccine.2005.11.064, 16406176.
13. Neumann-Haefelin C, Thimme R. Success and failure of virus-specific T cell responses in hepatitis C virus infection. Dig Dis 2011, 29:416-422. 10.1159/000329807, 21894013.
14. Bauer T, Sprinzl M, Protzer U. Immune control of hepatitis B virus. Dig Dis 2011, 29:423-433.
15. González-Navajas JM, Bellot P, Francés R, Zapater P, Muñoz C, García-Pagán JC, Pascual S, Pérez-Mateo M, Bosch J, Such J. Presence of bacterial-DNA in cirrhosis identifies a subgroup of patients with marked inflammatory response not related to endotoxin. J Hepatol 2008, 48:61-67. 10.1016/j.jhep.2007.08.012, 17998145.
16. Emmanuilidis K, Weighardt H, Maier S, Gerauer K, Fleischmann T, Zheng XX, Hancock WW, Holzmann B, Heidecke CD. Critical role of Kupffer cell-derived IL-10 for host defense in septic peritonitis. J Immunol 2001, 167:3919-3927.
17. Barsig J, Küsters S, Vogt K, Volk HD, Tiegs G, Wendel A. Lipopolysaccharide-induced interleukin-10 in mice: role of endogenous tumor necrosis factor-alpha. Eur J Immunol 1995, 25:2888-2893. 10.1002/eji.1830251027, 7589088.
18. Moore KW, O'Garra A, Malefyt RW, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993, 11:165-190. 10.1146/annurev.iy.11.040193.001121, 8386517.
19. Akdis CA, Blaser K. Mechanisms of interleukin-10-mediated immune suppression. Immunology 2001, 103:131-136. 10.1046/j.1365-2567.2001.01235.x, 1783236, 11412299.
20. Berry PA, Antoniades CG, Carey I, McPhail MJW, Hussain MJ, Davies ET, Wendon JA, Vergani D. Severity of the compensatory anti-inflammatory response determined by monocyte HLA-DR expression may assist outcome prediction in cirrhosis. Intensive Care Med 2011, 37:453-460. 10.1007/s00134-010-2099-7, 21161643.
21. Berres M-L, Schnyder B, Yagmur E, Inglis B, Stanzel S, Tischendorf JJW, Koch A, Winograd R, Trautwein C, Wasmuth HE. Longitudinal monocyte human leukocyte antigen-DR expression is a prognostic marker in critically ill patients with decompensated liver cirrhosis. Liver Int 2009, 29:536-543. 10.1111/j.1478-3231.2008.01870.x, 18795898.
22. Xing T, Li L, Cao H, Huang J. Altered immune function of monocytes in different stages of patients with acute on chronic liver failure. Clin Exp Immunol 2007, 147:184-188. 1810435, 17177978.
23. Kim OY, Monsel A, Bertrand M, Coriat P, Cavaillon J-M, Adib-Conquy M. Differential down-regulation of HLA-DR on monocyte subpopulations during systemic inflammation. Crit Care 2010, 14:R61. 10.1186/cc8959, 2887183, 20385017.
24. Flohé S, Lendemans S, Selbach C, Waydhas C, Ackermann M, Schade FU, Kreuzfelder E. Effect of granulocyte-macrophage colony-stimulating factor on the immune response of circulating monocytes after severe trauma. Crit Care Med 2003, 31:2462-2469. 10.1097/01.CCM.0000089640.17523.57, 14530752.
25. Cazzaniga M, Dionigi E, Gobbo G, Fioretti A, Monti V, Salerno F. The systemic inflammatory response syndrome in cirrhotic patients: relationship with their in-hospital outcome. J Hepatol 2009, 51:475-482. 10.1016/j.jhep.2009.04.017, 19560225.
26. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655. 10.1378/chest.101.6.1644, 1303622.
27. Papp M, Vitalis Z, Altorjay I, Tornai I, Udvardy M, Harsfalvi J, Vida A, Kappelmayer J, Lakatos PL, Antal-Szalmas P. Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections. Liver Int 2012, 32:603-611. 10.1111/j.1478-3231.2011.02689.x, 22145664.
28. Lünemann JD, Frey O, Eidner T, Baier M, Roberts S, Sashihara J, Volkmer R, Cohen JI, Hein G, Kamradt T, Münz C. Increased frequency of EBV-specific effector memory CD8+ T cells correlates with higher viral load in rheumatoid arthritis. J Immunol 2008, 181:991-1000. 2570434, 18606650.
29. Zimmermann HW, Seidler S, Nattermann J, Gassler N, Hellerbrand C, Zernecke A, Tischendorf JJW, Luedde T, Weiskirchen R, Trautwein C, Tacke F. Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis. PLoS One 2010, 5:e11049. 10.1371/journal.pone.0011049, 2883575, 20548789.
30. Koppelman B, Neefjes JJ, de Vries JE, de Waal Malefyt R. Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity 1997, 7:861-871. 10.1016/S1074-7613(00)80404-5, 9430231.
31. Lekkou A, Karakantza M, Mouzaki A, Kalfarentzos F, Gogos CA. Cytokine Production and Monocyte HLA-DR Expression as Predictors of Outcome for Patients with Community-Acquired Severe Infections. Clin Diagn Lab Immunol 2004, 11:161-167. 321326, 14715564.
32. von Baehr V, Döcke WD, Plauth M, Liebenthal C, Küpferling S, Lochs H, Baumgarten R, Volk HD. Mechanisms of endotoxin tolerance in patients with alcoholic liver cirrhosis: role of interleukin 10, interleukin 1 receptor antagonist, and soluble tumour necrosis factor receptors as well as effector cell desensitisation. Gut 2000, 47:281-287. 10.1136/gut.47.2.281, 1728013, 10896923.
33. Hershman MJ, Appel SH, Wellhausen SR, Sonnenfeld G, Polk HC. Interferon-gamma treatment increases HLA-DR expression on monocytes in severely injured patients. Clin Exp Immunol 1989, 77:67-70. 1541937, 2504520.
34. Vicente-Gutiérrez MM, Diez Ruiz A, Gil Extremera B, Bermúdez García JM, Gutiérrez Gea F. Low serum levels of alpha-interferon, gamma-interferon, and interleukin-2 in alcoholic cirrhosis. Dig Dis Sci 1991, 36:1209-1212. 10.1007/BF01307510, 1909948.
35. Trowsdale J. Antigen Presentation. Immunology 2006, 145-162. London: Mosby, Male DK, Brostoff J, Roitt IM, Roth D, 7.
36. Márquez M, Fernández-Gutiérrez C, Montes-de-Oca M, Blanco MJ, Brun F, Rodríguez-Ramos C, Girón-González JA. Chronic antigenic stimuli as a possible explanation for the immunodepression caused by liver cirrhosis. Clin Exp Immunol 2009, 158:219-229. 10.1111/j.1365-2249.2009.04005.x, 2768811, 19737142.
37. Yan Z, Yang DC, Neill R, Jett M. Production of tumor necrosis factor alpha in human T lymphocytes by staphylococcal enterotoxin B correlates with toxin-induced proliferation and is regulated through protein kinase C. Infect Immun 1999, 67:6611-6618. 97074, 10569782.
38. Hoechst B, Ormandy LA, Ballmaier M, Lehner F, Krüger C, Manns MP, Greten TF, Korangy F. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. Gastroenterology 2008, 135:234-243. 10.1053/j.gastro.2008.03.020, 18485901.
39. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009, 9:162-174. 10.1038/nri2506, 2828349, 19197294.
40. Landais E, Saulquin X, Houssaint E. The human T cell immune response to Epstein-Barr virus. Int J Dev Biol 2005, 49:285-292. 10.1387/ijdb.041947el, 15906243.
41. Bica I, McGovern B, Dhar R, Stone D, McGowan K, Scheib R, Snydman DR. Increasing Mortality Due to End-Stage Liver Disease in Patients with Human Immunodeficiency Virus Infection. Clin Infect Dis 2001, 32:492-497. 10.1086/318501, 11170959.
42. Duchini A, Viernes ME, Nyberg LM, Hendry RM, Pockros PJ. Hepatic Decompensation in Patients With Cirrhosis During Infection With Influenza A. Arch Intern Med 2000, 160:113-115. 10.1001/archinte.160.1.113, 10632312.
43. Wu H-P, Pan Y-H, Hua C-C, Shieh W-B, Jiang B-Y, Yu T-J. Pneumoconiosis and liver cirrhosis are not risk factors for tuberculosis in patients with pulmonary infection. Respirology 2007, 12:416-419. 10.1111/j.1440-1843.2007.01033.x, 17539848.